Vivian Strong

13PUBLICATIONS
86CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Epigenetics (incl. genome methylation and epigenomics)Molecular targetsCancer geneticsInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Oct 20, 2026
Selection and Management of Patients With Resectable Gastric or Gastroesophageal Junction Cancer Receiving Perioperative FLOT: A Modified Delphi Consensus Approach.

|Apr 22, 2026
Targeted Molecular Profiling of Circulating Cell-Free DNA in Patients With Gastroesophageal Adenocarcinoma.

|Jul 22, 2025
ctDNA as a Molecular Biomarker in the Phase II Trial of Imatinib plus Binimetinib in Patients with Advanced Gastrointestinal Stromal Tumor.

Ciara M Kelly, Martina Bradic, Sara Saunds

|Apr 29, 2025
Clinical Implications of The Cancer Genome Atlas Molecular Classification System in Esophagogastric Cancer.

Henry S Walch, Raktim Borpatragohain, Justin Jee

|Apr 16, 2025
Korea, Japan, Europe, and the United States: Why are guidelines for gastric cancer different?

Emily E Stroobant, Seong-Ho Kong, Maria Bencivenga

|Jan 09, 2025
Host Tissue Factors Predict Immune Surveillance and Therapeutic Outcomes in Gastric Cancer.

Miseker Abate, Emily E Stroobant, Teng Fei

Pageof 3

Frequent Collaborators

5 joint publications

Yelena Y Janjigian

4 joint publications

Daniela Molena

3 joint publications

Michael F Berger

3 joint publications

Henry Walch